RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer

Figure 6

IGSF9 expression in association with categorical clinicopathologic features. (a) Comparison of IGSF9 positivity in 8 pairs endometrioid carcinoma and noncancerous endometrial epithelia ( value = 0.008). (b) Comparison between noncancerous tissues and all the endometrioid carcinoma tissues from 56 patients ( value = 0.002). (c) Histological grade I (G1) versus grade II (G2). (d) Clinical stages. (e) Lymphovascular invasion. (f) Myometrial invasion ( value = 0.013).

(a)

(b)

(c)

(d)

(e)

(f)